Key facts
- This page summarizes Jun Yoon's Form 4 filing for Structure Therapeutics Inc. (GPCR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2026, 18:20.
Jun Yoon - 03 Mar 2026 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- GPCR
- Reported as of
- 03 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2026, 18:20:09 UTC
- Prior SEC filing
- 18 Mar 2025
- Next SEC filing
- 23 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jun Yoon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jun Yoon filed Form 4 for Structure Therapeutics Inc. (GPCR) on 05 Mar 2026.
Change
- Previous filing in this sequence was filed on 18 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001962414
Primary reporting owner
Yoon Jun
- Relationship
- CHIEF FINANCIAL OFFICER
- Address
- C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO
- Signature
- /s/ Jun Yoon
- Signature date
- 05 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GPCR
transaction
Ordinary Shares
Tax liability
- Transaction value
- Shares
- -22,305
- Change %
- -1.7%
- Price
- $20.99*
- Shares after
- 1,297,571
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
GPCR
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,554,586
- Date
- 03 Mar 2026
- Ownership
- See footnote
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
Footnote F2
Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
Footnote F3
By Jun Sik Yoon and Hayung Yang Yoon, Trustees of The Yoon Family Trust, dated December 11, 2019.